Fauna Bio

About:

Fauna Bio is a biotechnology company leveraging the science of hibernation to improve healthcare for humans.

Website: https://www.faunabio.com/

Twitter/X: FaunaBio

Top Investors: National Institutes of Health, True Ventures, National Human Genome Research Institute, GRIDS Capital, Boom Capital Ventures

Description:

Fauna Bio is developing new ways to treat human diseases, such as heart disease and neurodegenerative disease, by adopting mechanisms animals have developed for traits such as hibernation and deep-diving. Founded by three scientists who have intimate knowledge of the best science and resources from the field of non-model organisms, Fauna Bio leverages data from hundreds of species in order to help develop pre-clinical and early clinical testing for new therapeutics targeting human diseases.

Total Funding Amount:

$13.3M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Berkeley, California, United States

Founded Date:

2018-01-01

Founders:

Ashley Zehnder, Katie Grabek, Linda Goodman

Number of Employees:

11-50

Last Funding Date:

2022-01-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai